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Abstract. Cognitive reserve capacity may increase tolerance of neurodegenerative processes. However, its role regarding
amyloid- (A42) deposition in cognitively normal subjects is not well understood. We aimed to investigate the association
between areas showing A42-related structural changes and cognitive reserve proxies in cognitively intact subjects showing
normal or abnormal A42 cerebrospinal fluid (CSF) concentrations. Thirty-three subjects (aged 55–85) underwent lumbar punc-
ture and high resolution anatomical magnetic resonance imaging analyzed by voxel-based morphometry and cortical thickness
procedures. Subjects with abnormal A42 CSF levels showed significant left hippocampal atrophy and greater cortical thinning
in parietal, temporal, and frontal regions (including the supramarginal and the anterior cingulate gyrus) compared to subjects
with normal A42 CSF levels. Using a multivariate general linear model, we investigated the relationship between these areas and
cognitive reserve proxies. We found a significant relationship between decreased volume of the left hippocampus or decreased
cortical thickness of the right supramarginal gyrus and higher cognitive reserve proxies only in the group with abnormal A42
CSF levels. Thus, subjects with abnormal A42 CSF levels (which may be at a higher risk of developing Alzheimer’s disease)
and with high scores on cognitive reserve proxies may be tolerating a more advanced neurodegenerative process in critical
cortical and subcortical regions. The present results emphasize the relevance of evaluating cognitive reserve proxies, as well as
the importance of using neuroimaging techniques for early diagnosis in individuals with higher reserve.
Keywords: Aging, amyloid, cognitive reserve, hippocampus, structural MRI
INTRODUCTION
Recent research in cognitively healthy elderly indi-
viduals suggests that the pathophysiological process of
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Alzheimer’s disease (AD) begins decades before the
manifestation of clinical symptoms, that is, decades
before the diagnosis of clinical dementia. The most
commonly accepted model of AD proposes amyloid-
(A42) peptide accumulation as a key early event in the
pathophysiological process of AD [1–3]. This means
that older individuals may harbor pathological A42
deposition without presenting any clinical symptoms.
These asymptomatic individuals may in part represent
ISSN 1387-2877/13/$27.50 © 2013 – IOS Press and the authors. All rights reserved
716 E.M. Arenaza-Urquijo et al. / CR and Aβ42 -Related Structural Changes
the preclinical phase of AD. Interestingly, thanks to
previous autopsy [4–8] and ‘in vivo’ A42 imaging
and cerebrospinal fluid (CSF) studies [9–14], we know
that around one-third of these individuals with patho-
logical A42 deposition may not become symptomatic
before death. Differences in the lag phase between
A42 deposition and the appearance of symptoms may
be partially caused by interindividual differences in
brain reserve [15] and/or cognitive reserve [16]. Brain
reserve refers to interindividual differences in the neu-
ral substrate: for example, greater synaptic density or
a larger number of neurons to support normal function
despite pathological processes. Cognitive reserve is the
capacity of the adult brain to cope with more advanced
pathology by taking advantage of functional resources
(for example, the capacity to use alternative networks
or cognitive strategies to cope with the effects of the
pathology). Common indexes reflecting brain reserve
include increased intracranial or brain volumes while,
as operationalized in the present article, high scores on
proxy variables such as education, occupational sta-
tus, and lifetime exposure to cognitively stimulating
activities reflect cognitive reserve [17].
Recent Pittsburgh Compound B (PiB) and autopsy
studies in healthy elderly suggested greater brain
reserve in terms of larger temporal and hippocam-
pal areas in cognitively spared individuals with high
A42 deposition [18, 19]. Furthermore, several amy-
loid imaging and CSF studies suggested that cognitive
reserve may have a modulating role at different lev-
els by: i) influencing the relationship between A42
accumulation and cognition [20–22]; ii) acting directly
upon A42 accumulation, that is, slowing A42 depo-
sition [23]; or iii) permitting longer tolerance of
A42-related neural death or whole brain atrophy
[9]. This last point is of special interest since pre-
vious cognitive reserve studies in AD showed that
higher cognitive reserve proxies allow individuals to
cope with greater AD-related cortical thinning [24].
Inverse associations between cognitive reserve prox-
ies and brain structure or metabolism have frequently
been described in the multimodal cortex, for exam-
ple in frontal and temporoparietal areas in healthy
elderly and in patients with AD [25]. Interestingly,
the spatial pattern of A42 deposition [26] and A42-
related atrophy (e.g., [27]) overlap notably with areas
of the multimodal cortex. If cognitive reserve allows
individuals with preclinical AD to tolerate greater atro-
phy, especially in A42-related areas, this would have
implications for early diagnosis. However, the role of
cognitive reserve proxies in modulating gray matter
atrophy or cortical thinning is not well understood,
since both reductions [28, 29] and increases [30, 31]
in gray matter volume and cortical thickness as a func-
tion of cognitive reserve proxies have been reported
in previous studies in healthy elderly. These contra-
dictory findings may be related to the inclusion of
subjects at a higher risk of developing dementia (for
example, presenting high A42 deposition), and thus,
partially representing preclinical AD, in the major-
ity of neuroimaging studies. In this study we aimed
first to identify areas of A42-related cortical thin-
ning and gray matter loss by comparing elderly with
normal and abnormal A42 CSF levels. Second, we
aimed to investigate whether there were differences
in the relationships between cognitive reserve prox-
ies and A42-related gray matter atrophy in the two
groups. In agreement with the robust inverse associa-
tions between cognitive reserve proxies and measures
of brain integrity observed in AD, we hypothesized that
the associations would be reversed in the two groups
(i.e., positive in the group with normal A42 CSF lev-




Thirty-three volunteers were recruited from the
Alzheimer’s disease and other Cognitive Disor-
ders Unit, Neurology Service, at Hospital Cl´inic,
Barcelona, Spain. The study was approved by the local
ethics committee and all subjects gave informed writ-
ten consent. None of the participants selected had a
medical history of acute neurologic deficit compatible
with transient ischemic attack or stroke, or radiologic
evidence of stroke. Subjects did not meet criteria for
dementia or mild cognitive impairment (MCI), and
their cognitive performance was not less than −1.5 SD
on any test included in the neuropsychological exami-
nation [32]. Mini-Mental State Examination (MMSE)
scores were between 24 and 30. On the Global Deteri-
oration Scale (GDS) rating [33], all subjects presented
normal functional capacity (GDS ratings 1 or 2).
CSF analyses and group classification
Ten milliliters of CSF were obtained during the
morning (9:00 to 12:00 a.m) and samples were cen-
trifuged and stored in polypropylene tubes at 80◦C.
The A1-42 at threonine 181 in CSF was measured by
enzyme-linked immunosorbent assay (Innogenetics,
Ghent, Belgium). Patients were not fasted. As patients
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Table 1
Demographical variables (including cognitive reserve proxies and years of education), global cognitive function (Mini-Mental State Examination,
MMSE), cerebrospinal fluid (CSF) characteristics, and APOE status of the subjects included in the study. P-tau: phosphorylated tau
Normal A42 CSF levels mean (SD) Abnormal A42 CSF levels mean (SD) T-test/Chi square (p value)
n 16 17 -
Male: Female 6:10 8:9 0.30 (0.57)
Age 68.06 (5.66) 72.41 (7.83) −1.81 (0.07)
Cognitive reserve proxy 13.60 (5.08) 12.38 (4.81) 0.84 (0.40)
Years of education 10.31 (4.95) 9.52 (4.72) 0.46 (0.64)
MMSE 28.31 (1.14) 28.05 (1.48) 0.55 (0.58)
APOE 4 carriers (%) 3 (18.8 %) 6 (35.3%) 1.13 (0.28)
CSF A42 (pg/ml) 688.72 (129.93) 372.80 (101.60) 7.80 (0.001)
CSF p-tau (pg/ml) 57.81 (21.19) 73.03 (45.83) 13.21 (0.23)
were participants in a quality control program, deter-
minations in our laboratory of A42 at threonine 181
values were within mean 2 SD. A cutoff of 500 pg/mL
[34] was used to dichotomize the sample into 16 sub-
jects with abnormal A42 CSF levels (<500 pg/mL)
and 17 with normal A42 CSF levels (>500 pg/mL)
(see Table 1). The percentage of subjects showing
abnormal A42 CSF levels was higher than might be
expected in the population [8, 11].
Individual cognitive reserve estimations
All but two subjects included in the study under-
went cognitive reserve proxy assessment. Proxies of
cognitive reserve were estimated using a customized
questionnaire [35] focusing on years of education
and lifespan cognitive activities. Information regard-
ing years of education was quantified and ranged
from “no formal education” to “university education”.
In detail, they were coded as 0 = no formal edu-
cation, 1 = self-taught reader and writer, 2 = primary
school, 3 = secondary school, and 4 = higher or univer-
sity education. Occupational information was coded as
follows: 0 = unskilled, 1 = skilled manual, 2 = skilled
non-manual or technician, 3 = professional (univer-
sity degree), and 4 = manager or director (university
degree). We also recorded information about musi-
cal studies, languages, and lifetime involvement in
leisure activities such as reading and playing intellec-
tual games and their frequency. The questionnaire has a
maximum score of 25, with 25 representing the highest
cognitive reserve.
Neuropsychological and functional assessment
Participants were administered a one-hour neu-
ropsychological battery test by a trained neuropsychol-
ogist. The battery included memory, language, praxis,
visual perception, and frontal functions assessment.
All neuropsychological scores were adjusted for age
and educational level. Normative neuropsychological
data and the neuropsychological battery have been
described in detail elsewhere [32].
MRI acquisition and processing
High resolution 3D structural dataset (T1-weighted
MP-RAGE, TR = 2300 ms, TE = 2.98 ms, 240 slices,
FOV = 256 mm, matrix size = 256 × 256; Slice thick-
ness = 1 mm) were acquired on a 3T MRI scanner
(Magnetom Trio, Tim, Siemens Medical Systems, Ger-
many) for the 33 subjects.
Cortical reconstruction of the structural images was
performed with the FreeSurfer image analysis suite,
version 4.3.1. (http://surfer.nmr.mgh.harvard.edu/).
The procedures carried out with FreeSurfer software
include removal of non-brain data, intensity normal-
ization [36], tessellation of the gray matter/white
matter boundary, automated topology correction [37,
38], and accurate surface deformation to identify tis-
sue border [39, 40]. Reconstructed and registered
individual cortical thickness maps were smoothed
using a Gaussian Kernel of 15 mm Full-Width
Half Maximum (FWHM). Structural MRI data were
also processed with FSL-VBM, a voxel-based mor-
phometry style analysis included in FSL suite [41]
(http://www.fmrib.ox.ac.uk/fsl). First, brain extraction
on all T1 images was carried out [42]. All brain-
extracted images were segmented into gray matter,
white matter, and CSF [43]. Gray matter images were
then registered to the gray matter ICBM-152 template.
The registered gray matter images were concatenated
into a 4D image and averaged to create the study-
specific gray matter template based on a non-linear
registration. All the gray matter images were non-
linearly registered to the study-specific template and
concatenated into a 4D image introducing a compen-
sation or modulation for the non-linear component of
the transformation (Jacobian of the warp field). Finally
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Table 2
Neuropsychological performance of the two groups included in the study. Between group statistical differences are reported. FCSRT: Free and
cued selective reminding test; ROCF: Rey-Osterrieth Complex Figure; CERAD battery: Consortium to Establish a Registry of Alzheimer’s
Disease; VOSP: Visual Object and Space Perception battery; WAIS: Weschler Adult Intelligence Scale; TMT: Trail Making Test
Normal A42 CSF levels mean (SD) Abnormal A42 CSF levels mean (SD) T-test (p value)
FCSRT: Learning 25.38 (5.23) 21.06 (7.53) 1.88 (0.07)
FCSRT: Total learning 41.00 (7.27) 39.94 (6.67) 0.43 (0.67)
FCSRT: Recall 10.00 (1.51) 8.19 (3.56) 1.87 (0.07)
FCSRT: Total recall 14.25 (1.23) 13.63 (2.50) 0.89 (0.38)
ROCF: Immediate recall 17.87 (4.12) 14.97 (5.97) 1.56 (0.13)
ROCF: Delayed recall 18.25 (4.05) 14.88 (6.45) 1.73 (0.09)
Boston naming test 54.62 (4.54) 53.50 (4.54) 0.55 (0.59)
Semantic fluency (Animals) 18.06 (4.84) 18.18 (4.38) −0.07 (0.94)
Phonologic fluency (F,A,S) 32.13 (15.33) 29.06 (11.44) 0.65 (0.52)
CERAD: Praxis 10.25 (1.34) 10.41 (.87) −0.41 (0.68)
VOSP : Number location 9.06 (1.12) 8.69 (1.74) 0.72 (0.48)
VOSP: Incomplete letters 19.44 (.96) 19.19 (1.76) 0.49 (0.62)
Digit (WAIS III): Direct 8.08 (1.66) 8.21 (1.97) −0.19 (0.85)
Digit (WAIS III): Inverse 5.08 (1.55) 5.21 (1.63) −0.22 (0.82)
Digit (WAIS III): Total 13 (2.97) 13.13 (2.72) −0.12 (0.90)
TMT A 56.67 (17.21) 50.82 (17.05) 0.39 (0.69)
TMT B 160.25 (82.01) 154.35 (76.54) 0.21 (0.83)
they were smoothed by a range of Gaussian kernels
(sigma = 2, 3, 4 mm). The concatenated processed data,
smoothed at 3 sigma (approximately 7 mm FWHM),
was used to run randomize.
Statistical analyses
Demographical and neuropsychological variables
Student’s t-test or chi square was performed with
Statistical Package for the Social Sciences (SPSS) for
Windows (V.17.0). Results were considered as signif-
icant at p < 0.05.
Cortical thickness and VBM analyses:
Between-group comparison
Statistical analysis of differences in cortical thick-
ness maps (elderly with abnormal versus elderly
with normal A42 CSF) were tested in both hemi-
spheres using vertex-wise t-test as implemented in
QDEC from FreeSurfer. We used a standard gen-
eral linear model (GLM) design and corrected for
Family-Wise Error (FWE) using a Monte-Carlo
permutation-based testing (10000 permutations). For
the voxel-by-voxel between-group comparison (sub-
jects with normal/abnormal A42 CSF), a standard
GLM design (permutations = 5000), and threshold-free
cluster enhancement correction was used, controlling
FWE rate. In order to isolate the role of A42 lev-
els on brain structure, we included demographical
variables (age and gender), APOE status (categorized
as APOE/4-allele carrier/non-carrier, see results) and
CSF p-tau levels [44, 45] as covariates.
Group by cognitive reserve proxy interaction
analyses
Volume and cortical thickness of the significant
clusters showing between-group differences (subjects
with abnormal < subjects with normal A42 CSF, see
results) were extracted. We carried out a multivari-
ate GLM as implemented in SPSS. Cortical thickness
and gray matter volume of the significant clusters
were introduced as dependent variables, group as cat-
egorical predictor of the model (fixed factor), and
cognitive reserve proxies as independent variable. We
investigated the interactive effect of group and cogni-
tive reserve proxies on left hippocampal volume and
right supramarginal, left caudal cingulate, left supe-
rior temporal, and left frontal parsopercularis cortical
thickness. For the statistically significant results, mul-
tiple regression coefficients were calculated separately
in each group. Results were considered as significant
at p < 0.05.
RESULTS
Demographical variables and neuropsychological
assessment
The two groups did not differ in any of the demo-
graphical variables studied (see Table 1 for details)
or cognitive function (see Table 2). However, the
between-group comparison showed a trend toward sig-
nificance (p = 0.07) for learning and delayed recall
memory performances.
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Differences in cortical thickness and gray matter
volumes (Elderly with Abnormal <Normal Aβ42
CSF Levels)
Statistically significant cortical thickness reductions
were observed in subjects with abnormal A42 CSF
levels than in those with normal A42 CSF levels
at p < 0.05 FWE corrected. The anatomical pattern
included superior and middle temporal areas, frontal
areas (lateral orbitrofrontal, parsopercularis, parstrian-
gularis, rostral middle frontal, caudal middle frontal,
superior frontal, and caudal cingulate) in the left
hemisphere, and parietal regions including the supra-
marginal gyrus in the right hemisphere (see Fig. 1A,
Table 3). Moreover, the voxel-based statistical analyses
for the group comparison revealed gray matter differ-
ences in the left hippocampus. Elderly with abnormal
A42 CSF levels showed lower hippocampal volume
than those with normal A42 CSF levels (see Fig. 1B,
Table 3). When a less strict correction was used for the
VBM analysis (uncorrected p < 0.001), the pattern of
atrophy was extended to temporal and frontal areas
(data not shown). No results were found when the
opposite contrast (subjects with abnormal > subjects
with normal A42 CSF levels) was tested.
Relationships between cognitive reserve proxies,
volume, and cortical thickness
We observed a statistically significant group-
by-cognitive reserve proxy interaction in the left
hippocampal volume (F = 6.19; p = 0.02) and the right
supramarginal gyrus (F = 7.17; p = 0.01) (Fig. 2). Cor-
relation coefficients showed a significant negative
association between left hippocampal volume and cog-
nitive reserve proxies (see Fig. 2, in red, r = −0.554;
p = 0.03) and between the cortical thickness of the right
supramarginal gyrus and cognitive reserve proxies (see
Fig. 2, in red, r = 0-0.516; p = 0.04) in elderly with
abnormal A42 CSF levels. This association was not
significant (hippocampal volume: r = 0.17, p = 0.52;
supramarginal cortical thickness: r = 0.38, p = 0.16), in
elderly with normal A42 CSF levels.
DISCUSSION
In the present study, we aimed to investigate the
differences in the relationship between areas showing
A42-related structural changes and cognitive reserve
proxies in healthy elderly subjects showing biomarker
positivity for CSF A42 levels (at higher risk of devel-
oping AD) compared to elderly with normal A42
levels. We first identified regions showing differences
in regional cortical thinning and gray matter atrophy
between groups. Elderly with abnormal A42 CSF
levels showed greater cortical thinning in temporal,
parietal, and frontal regions and greater left hippocam-
pal atrophy than elderly with normal A42 CSF levels.
Higher cognitive reserve proxies were related to greater
hippocampal atrophy and cortical thinning of the
supramarginal gyrus only among subjects with abnor-
mal A42 CSF levels, suggesting that among these
individuals those with higher cognitive reserve proxies
are tolerating greater A42-related atrophy and cortical
thinning.
Our results showing greater cortical thinning and
regional atrophy in elderly with abnormal A42
CSF levels corroborate previous studies demonstrat-
ing structural changes in these individuals. The pattern
of thinning that we found (i.e., superior temporal,
supramarginal gyrus, anterior cingulate, and inferior
frontal) shows differences as well as similarities with
regard to previous studies investigating gray matter
atrophy related to A42 deposition as measured by
PET imaging or CSF levels. Dickerson et al. [27]
demonstrated a signature of AD in cortical anatomy
by comparing healthy elderly individuals to mild AD
subjects. This cortical signature of mild AD included
the temporal and parietal cortex (including angular
and supramarginal gyrus and precuneus) and the infe-
rior frontal gyrus. In the same study, these areas were
defined as regions of interest (ROI) and investigated
in a small sample of cognitively healthy elderly with
high brain amyloid binding (as detected by PiB-PET
imaging). Only the temporal pole and, as we reported
in the present study, the inferior frontal cortex showed
significant cortical thinning compared to subjects with
low brain amyloid binding. However, Dickerson et
al. [27] found a pattern of subtle thinning in all the
regions, including areas described in the present study
such as the supramarginal gyrus. Anterior cingulate
and superior temporal lobe were not regions described
in Dickerson et al.’s proposed AD signature; however,
cortical thinning of these areas has been reported in
previous studies comparing cognitively normal indi-
viduals with high and low A42 deposition [46–48].
The discrepancies in the A42-related cortical thinning
in cognitively healthy elderly described in the differ-
ent studies are most likely the result of methodological
differences. Unlike in the present study, ROI-based
approaches [27, 46, 48] are mainly used, although a
combination of ROI-based and whole brain approaches
has also been applied [47] to study elderly with
abnormal A42 CSF levels. Measures of amyloid









Fig. 1. Results of cortical thickness (A) and voxel-based morphometry analyses (B) showing differences between healthy elderly subjects with
normal versus abnormal A42 CSF levels (abnormal < normal A42 CSF levels). All results are FWE-corrected.
Table 3
Cortical thickness and voxel-based morphometry (VBM) results for between-group comparison. Reported clusters are corrected for multiple
comparisons (FWE). The coordinates x, y and z refer to the anatomical location, indicating Tailairach standard stereotactic space. L: left, R: right
Cortical area/ Cluster size Coordinates Normal A42 Abnormal A42 p value
Brain region (mm2) x y z CSF levels mean (SD) CSF levels mean (SD)
Cortical thickness
L Superior temporal 2580.30 −51.9 −15.6 −6.7 2.72 (0.12) 2.50 (0.10) 0.009
L Frontal parsopercularis 4480.98 −47.4 25.2 10.1 2.60 (0.16) 2.41 (0.10) 0.008
L Caudal cingulate 2661.77 −1 18.3 17.7 2.84 (0.19) 2.65 (0.16) 0.008
R Supramarginal 2943.54 43.5 −32.7 24.7 2.56 (0.11) 2.34 (0.20) 0.002
VBM
L Hippocampus 73 −22 −14 −18 0.63 (0.04) 0.53 (0.05) 0.035
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Fig. 2. Scatter plots showing interactions between cognitive reserve proxies and A42-related areas of cortical thinning or atrophy in elderly
with normal versus abnormal A42 CSF levels. In red, statistically significant correlation coefficients (see Results for statistical details). Cth:
cortical thickness; CR: cognitive reserve; R: right; L: left.
deposition (PiB-PET imaging or CSF levels), differ-
ences in the criteria used to dichotomize the sample,
and the differential treatment of potential nuisance
variables vary across studies and may lead to dif-
ferences. For example, in the present study we were
specifically interested in the relationships between
A42 and cognitive reserve proxies (see Introduc-
tion), and so we introduced APOE status and p-tau
levels as covariates in order to isolate A42-related
brain changes. Finally, the mean age of our sub-
jects with abnormal A42 levels was lower than in
the rest of the studies. This may partially explain
why we did not find differences in the areas that
have been described as having an important role in
the preclinical phase of AD [49] and showing A42-
related cortical thinning in cognitively healthy elderly
[46, 48] such as the posterior cingulate or precuneus.
Along these lines, a previous study [46] found that
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these regions showed age-related cortical thickness
reductions. When the between-group comparison was
carried out without controlling for age, gender, p-tau
levels, and APOE status, precuneus and parahippocam-
pal regions also showed A42-related cortical thinning
(data not shown). Overall, our cortical thickness results
lend support to earlier PiB and CSF studies suggesting
that A42 deposition in normal elderly may represent
the preclinical or asymptomatic AD phase.
When VBM analyses were carried out in a whole
brain manner, we found a significant difference in the
subjects with abnormal A42 CSF levels compared to
those with normal A42 CSF levels circumscribed to
the left hippocampus. The finding of A42-related hip-
pocampal atrophy in this study is in agreement with
previous studies in cognitively healthy elderly harbor-
ing high A42 deposition [10, 48, 50], although con-
flicting results have also been reported [51]. Mormino
et al. [50] studied the relationship between hippocam-
pal volume, episodic memory, and A42 deposition (as
measured by PiB imaging) in three independent sam-
ples of cognitively healthy elderly. They found that
higher A42 deposition was associated with smaller
hippocampal volume across the three samples. Storand
et al. [48] observed smaller hippocampal volumes in
29 participants with high A42 deposition (measured
by PIB-PET imaging). Finally comparing high and
low PiB retention in cognitively normal subjects, Jack
et al. [10] found that the hippocampus on average
was more atrophic (though not significantly so) in
the high PiB subgroup. With regard to the asymmetry
shown in the present study (only the left hippocampus
showed A42-related atrophy), previous investigations
have consistently reported an asymmetry (left less than
right) between the left and the right hippocampal vol-
umes in healthy subjects, MCI, and AD [52]; the left
hippocampus thus showed greater atrophy.
The differences in the results using VBM versus
cortical thickness methods may appear surprising.
However, previous studies also presented discrep-
ancies [53, 54] due, perhaps, to differences in the
sensitivity of the two measures. Cortical thickness is
thought to be a more sensitive measure, because gray
matter volume (measured by VBM) is dependent on
the local cortical surface (and hence cortical folding)
as well as on the local cortical thickness [55]. Based
on previous evidence of neurodegenerative and psychi-
atric diseases using the same combination of methods
[56, 57], we concluded that the combination of the two
methods may provide complementary information. It
is important to note that when a less strict statistical
threshold was used for the VBM analyses (uncorrected
p < 0.001, data not shown) more extended regions
of the temporal lobe and the frontal lobe showed
greater atrophy in subjects with abnormal A42 CSF
levels.
The main finding of our study was that there was a
group-by-cognitive reserve proxy interactional effect
on the left hippocampus and right supramarginal gyrus.
Follow-up analyses showed that cognitive reserve
proxies were significantly and negatively associated
with hippocampal volumes and supramarginal cor-
tical thinning in subjects with abnormal A42 CSF
levels but not in those with normal A42 CSF lev-
els. As groups did not differ on cognitive tests, the
most straightforward interpretation within the theoret-
ical framework of the reserve hypothesis is that elderly
subjects with abnormal A42 CSF levels and with high
cognitive reserve proxies exhibit more advanced gray
matter atrophy while remaining cognitively normal.
Although there were no significant between-group dif-
ferences in task performance, memory performance
showed a trend toward significance (p = 0.07). Some
studies [13, 18, 50], but not all [10], found A42 depo-
sition to be related to episodic memory performance.
We therefore repeated the GLM (see Methods), con-
trolling for memory performance. The interactional
effect (group-by-cognitive reserve proxy) remained
significant (data not shown). This suggests that the
interactional effect is independent of interindividual
differences in memory performance. Therefore, in
accordance with the cognitive reserve theory, and tak-
ing A42 CSF levels as a surrogate for pathology, our
results suggest that at a comparable level of cognitive
performance, the underlying neuropathological pro-
cess is more advanced in patients with higher cognitive
reserve proxies [51].
Inverse relationships between cognitive reserve
proxies and brain measures have been consistently
found in AD studies [25]. This is corroborated by the
results of the present study if we consider that our
subjects with abnormal A42 CSF levels may in part
represent the preclinical phase of AD. Nevertheless,
previous studies in healthy elderly found that mental
activity across the lifespan correlated with a reduced
rate of hippocampal atrophy [58] or that healthy elderly
subjects with higher education presented reduced mean
diffusivity (indicating higher integrity) in the bilat-
eral hippocampus [59]. Following these investigations,
we might have expected to find a positive correla-
tion reflecting more preserved hippocampal structure
as a function of cognitive reserve in elderly with nor-
mal A42 CSF levels. However, we did not record
this observation, possibly due to a lack of statistical
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power caused by the relatively reduced sample size.
It should also be borne in mind that the aim of this
study was to investigate the differential relationships
between cognitive reserve proxies and brain structure
in A42-related areas within the two groups; there-
fore, we carried out analyses only in areas showing
A42-related atrophy. Hence, we cannot exclude the
possibility that a group-by-cognitive reserve proxy
effect or a relationship between cognitive reserve prox-
ies and brain structure may exist in other brain regions
that were not targeted in the present study. Actually,
we tested this possibility in subsequent analyses and
results tended to identify other areas besides the ones
previously described (parahippocampus, inferior and
superior temporal lobe in VBM analyses, and pre-
central gyrus in cortical thickness analysis). However,
these results did not survive multiple comparison cor-
rection (data not shown). Thus, further studies are
needed to clarify this issue.
The implications that these results may have for
diagnosis or prognosis are based on previous evidence.
On the one hand, an existing longitudinal study on sub-
jects cognitively normal at base line [60] showed that
those converting to dementia had significantly fewer
years of education (a proxy of cognitive reserve) than
non-converters; both education and CSF levels were
predictors of conversion. On the other hand, the rele-
vance of hippocampal volume to the conversion from
MCI to AD has been stressed by several investiga-
tors [61–63]. Furthermore, we found greater cortical
thinning in the supramarginal gyrus in elderly subjects
with abnormal A42 CSF levels and higher cognitive
reserve proxies; this area has been shown to present
gray matter loss in patients with MCI. Moreover, lon-
gitudinal studies investigating the conversion to AD
showed gray matter loss in this region (for a review,
see [64]). Finally, a follow-up study comparing MCI
patients either converting to dementia or remaining
stable [22] reported that MCI converters with higher
education had significantly lower A42 levels than
those with lower education. This suggests that the accu-
mulation of plaques was more pronounced in the highly
educated group.
This study has several limitations. The first is the
relatively small number of subjects included, which
may have lessened the statistical power. However, the
differences between elderly patients with normal and
abnormal A42 CSF levels were observed after cor-
recting for multiple comparisons (FWE corrected) and
adjusting for the main confounding variables (age,
gender, APOE, and p-tau status). Moreover, the cross-
sectional design of the study does not allow us to test
the hypothesis that elderly with abnormal A42 CSF
levels and higher proxies of cognitive reserve may be
at later stages of the AD preclinical phase (and will
thus convert faster to MCI or AD). Solely longitudinal
studies providing information about conversion to MCI
or AD could properly test this hypothesis. Although
functional resources might compensate for greater hip-
pocampal atrophy in elderly with abnormal A42 CSF
levels and higher cognitive reserve proxies, our study
does not provide direct evidence of the implementation
of cognitive reserve mechanisms in brain structure or
brain functionality. Probably, functional imaging stud-
ies may help to clarify the mechanisms, underlying the
fact that despite greater hippocampal atrophy, elderly
with abnormal A42 CSF levels and high cognitive
reserve proxies can perform at a similar cognitive level.
Also, the group by cognitive reserve proxy interaction
was not highly significant (see Results), thus further
studies in larger samples are needed in order to con-
firm this finding. On a different subject, a strength of
our study is that we used a comprehensive measure
of cognitive reserve, including not only years of edu-
cation but also cognitively stimulating activities. We
also included subjects with and without memory com-
plaints (see Methods). It has been suggested [18] that
brain A42 burden is not related to brain atrophy in
healthy subjects without memory complaints but only
in subjects with memory complaints, thus the inclu-
sion of subjects with memory complaints may have
influenced our results. This issue needs to be studied
in future investigations.
In summary, we provide evidence that in elderly peo-
ple with abnormal A42 CSF levels, those with greater
cognitive reserve proxies can tolerate more atrophy
while remaining cognitively normal. Based on our
findings, we hypothesize that elderly with abnormal
A42 CSF levels with higher cognitive reserve proxies
are expressing higher neural compensation [16] (i.e.,
tolerating greater hippocampal atrophy) than elderly
with abnormal A42 CSF levels with lower cognitive
reserve proxies. These observations imply that cogni-
tive reserve is significant even in cognitively preserved
elderly adults that may represent in part the preclini-
cal phase of AD, that is, prior to clinical symptoms. At
the clinical level, these results emphasize the relevance
of evaluating cognitive reserve proxies in combina-
tion with neuroimaging techniques for early diagnosis.
Finally, we demonstrate that A42 status could have
been a confounding factor in earlier studies combin-
ing cognitive reserve with neuroimaging measures in
samples of healthy elderly defined using clinical and
neuropsychological information.
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